Analystreport

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at SunTrust Banks, Inc. to $117.00. They now have a "buy" rating on the stock.

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com